Allianz Asset Management
NBIX icon

Allianz Asset Management’s Neurocrine Biosciences NBIX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$2.08M Sell
16,552
-8,486
-34% -$1.07M ﹤0.01% 1097
2025
Q1
$2.77M Sell
25,038
-3,380
-12% -$374K ﹤0.01% 1038
2024
Q4
$3.88M Buy
28,418
+69
+0.2% +$9.42K 0.01% 949
2024
Q3
$3.27M Buy
28,349
+6,676
+31% +$769K ﹤0.01% 990
2024
Q2
$2.98M Sell
21,673
-5,795
-21% -$798K ﹤0.01% 976
2024
Q1
$3.79M Sell
27,468
-2,140
-7% -$295K 0.01% 895
2023
Q4
$3.9M Sell
29,608
-52,518
-64% -$6.92M 0.01% 850
2023
Q3
$9.24M Sell
82,126
-1,746
-2% -$196K 0.02% 593
2023
Q2
$7.91M Sell
83,872
-157,121
-65% -$14.8M 0.01% 594
2023
Q1
$24.4M Sell
240,993
-9,936
-4% -$1.01M 0.04% 391
2022
Q4
$30M Buy
250,929
+73,619
+42% +$8.79M 0.06% 334
2022
Q3
$18.8M Sell
177,310
-68,354
-28% -$7.26M 0.04% 452
2022
Q2
$23.9M Sell
245,664
-20,358
-8% -$1.98M 0.02% 604
2022
Q1
$24.9M Buy
266,022
+67,248
+34% +$6.3M 0.02% 645
2021
Q4
$16.9M Sell
198,774
-22,653
-10% -$1.93M 0.01% 788
2021
Q3
$21.2M Buy
221,427
+58,850
+36% +$5.64M 0.02% 680
2021
Q2
$15.8M Buy
162,577
+84,096
+107% +$8.18M 0.01% 686
2021
Q1
$7.63M Buy
78,481
+906
+1% +$88.1K 0.01% 868
2020
Q4
$7.44M Buy
77,575
+26,844
+53% +$2.57M 0.01% 921
2020
Q3
$4.88M Buy
50,731
+10,046
+25% +$966K 0.01% 977
2020
Q2
$4.96M Sell
40,685
-3,172
-7% -$387K 0.01% 1015
2020
Q1
$3.8M Sell
43,857
-12,239
-22% -$1.06M 0.01% 1071
2019
Q4
$6.03M Sell
56,096
-57,135
-50% -$6.14M 0.01% 1118
2019
Q3
$10.2M Sell
113,231
-44,625
-28% -$4.02M 0.01% 917
2019
Q2
$13.3M Sell
157,856
-6,749
-4% -$570K 0.01% 871
2019
Q1
$14.5M Sell
164,605
-121,765
-43% -$10.7M 0.01% 808
2018
Q4
$20.4M Sell
286,370
-81,536
-22% -$5.79M 0.02% 609
2018
Q3
$45.2M Sell
367,906
-1,663
-0.4% -$204K 0.04% 410
2018
Q2
$36.3M Sell
369,569
-26,531
-7% -$2.61M 0.04% 452
2018
Q1
$32.8M Buy
396,100
+45,775
+13% +$3.8M 0.03% 515
2017
Q4
$27.2M Buy
350,325
+310,214
+773% +$24.1M 0.02% 608
2017
Q3
$2.46M Buy
40,111
+75
+0.2% +$4.6K ﹤0.01% 1428
2017
Q2
$1.85M Buy
+40,036
New +$1.85M ﹤0.01% 1506
2017
Q1
Sell
-224,869
Closed -$8.7M 2094
2016
Q4
$8.7M Sell
224,869
-3,876
-2% -$150K 0.01% 1043
2016
Q3
$11.5M Sell
228,745
-64,431
-22% -$3.25M 0.01% 943
2016
Q2
$13.3M Sell
293,176
-11,231
-4% -$510K 0.01% 831
2016
Q1
$12M Buy
304,407
+95,767
+46% +$3.79M 0.01% 858
2015
Q4
$11.8M Buy
208,640
+18,600
+10% +$1.05M 0.01% 848
2015
Q3
$7.56M Buy
190,040
+26,165
+16% +$1.04M 0.01% 966
2015
Q2
$7.83M Sell
163,875
-103,664
-39% -$4.95M 0.01% 1002
2015
Q1
$10.6M Sell
267,539
-192,881
-42% -$7.66M 0.01% 804
2014
Q4
$10.3M Buy
460,420
+205,210
+80% +$4.58M 0.01% 788
2014
Q3
$4M Sell
255,210
-23,000
-8% -$360K ﹤0.01% 1006
2014
Q2
$4.13M Sell
278,210
-3,190
-1% -$47.3K 0.01% 977
2014
Q1
$4.53M Buy
281,400
+55,000
+24% +$886K 0.01% 969
2013
Q4
$2.12M Hold
226,400
﹤0.01% 1183
2013
Q3
$2.56M Sell
226,400
-205,100
-48% -$2.32M ﹤0.01% 1107
2013
Q2
$5.77M Buy
+431,500
New +$5.77M 0.01% 832